GOVX (Geovax Labs) Total Premiums Earned

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GOVX Geovax Labs Inc GOVX
26 GF Score
Price $0.37
! 1 Warning Sign
View Full Analysis

What is Geovax Labs Total Premiums Earned?

Total Premiums Earned only applies to insurance companies.

GOVX
26GF Score
Geovax Labs Inc GOVX
Total Premiums Earned is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Geovax Labs Business Description

Address 1955 Lake Park Drive, Suite 300, Smyrna, GA, USA, 30080
GeoVax Labs Inc. is a clinical-stage biotechnology company based in the United States that develops human vaccines and immunotherapies for infectious diseases and solid tumor cancers. Its pipeline is built on proprietary vaccine platforms, including modified vaccinia Ankara (MVA) and virus-like particle technologies. Lead candidates include GEO-MVA for mpox, smallpox, and other poxviruses; Gedeptin, an oncolytic gene-directed therapy evaluated in head and neck cancers; and GEO-CM04S1, a multi-antigen COVID-19 vaccine. The company also pursues earlier-stage programs against other infectious threats. As a clinical-stage business, Geovax does not yet generate substantial product revenue; it funds operations primarily through government research contracts, grants, collaborations, and equity financings. Its activities center on preclinical and clinical development, regulatory interactions, and partnerships with academic and government institutions, with target markets in the United States and globally for vaccine and oncology products.
26GF Score

Get the complete analysis for GOVX

Total Premiums Earned is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.37
Price